Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Total Liabilities (2018 - 2025)

Exagen (XGN) has disclosed Total Liabilities for 8 consecutive years, with $40.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 15.43% year-over-year to $40.6 million, compared with a TTM value of $40.6 million through Dec 2025, up 15.43%, and an annual FY2025 reading of $40.6 million, up 15.43% over the prior year.
  • Total Liabilities was $40.6 million for Q4 2025 at Exagen, down from $44.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $45.9 million in Q1 2022 and bottomed at $30.7 million in Q3 2024.
  • Average Total Liabilities over 5 years is $37.8 million, with a median of $37.0 million recorded in 2021.
  • The sharpest move saw Total Liabilities decreased 28.82% in 2024, then skyrocketed 45.38% in 2025.
  • Year by year, Total Liabilities stood at $38.5 million in 2021, then rose by 13.64% to $43.8 million in 2022, then fell by 21.73% to $34.2 million in 2023, then rose by 2.62% to $35.1 million in 2024, then rose by 15.43% to $40.6 million in 2025.
  • Business Quant data shows Total Liabilities for XGN at $40.6 million in Q4 2025, $44.7 million in Q3 2025, and $37.7 million in Q2 2025.